RT Book, Section A1 Papadakis, Maxine A. A1 McPhee, Stephen J. A1 Rabow, Michael W. A1 McQuaid, Kenneth R. SR Print(0) ID 1193123768 T1 Rheumatologic, Immunologic, & Allergic Disorders Year in Review T2 Current Medical Diagnosis & Treatment 2023 YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264687343 LK accessmedicine.mhmedical.com/content.aspx?aid=1193123768 RD 2024/03/28 AB Because rituximab reduces the humoral immune response, it should be used with caution during the COVID-19 pandemic as multiple studies suggest a higher risk of mortality from COVID-19 in patients using this medication.